HomeHNSA • STO
add
Hansa Biopharma AB
Previous close
kr 31.88
Day range
kr 32.20 - kr 33.10
Year range
kr 19.58 - kr 42.98
Market cap
3.29B SEK
Avg Volume
327.64K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 75.99M | 134.99% |
Operating expense | 176.02M | -7.59% |
Net income | -169.90M | 38.65% |
Net profit margin | -217.19 | 74.64% |
Earnings per share | -1.62 | 60.29% |
EBITDA | -124.28M | 27.32% |
Effective tax rate | -0.24% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 701.08M | 72.99% |
Total assets | 1.17B | 45.73% |
Total liabilities | 1.25B | -10.04% |
Total equity | -88.99M | — |
Shares outstanding | 101.76M | — |
Price to book | -36.64 | — |
Return on assets | -32.74% | — |
Return on capital | -51.50% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -169.90M | 38.65% |
Cash from operations | -195.92M | -32.56% |
Cash from investing | — | — |
Cash from financing | 645.96M | 34,533.05% |
Net change in cash | 449.01M | 402.85% |
Free cash flow | -45.42M | 69.26% |
About
Founded
2007
Website
Employees
125
